
Dermatologicals in Japan
Description
Dermatologicals in Japan
Dermatologicals is set to see similar slow current value growth in 2022 as witnessed in 2021, but performances are expected to vary depending on the category. For example, haemorrhoid treatments, hair loss treatments and cold sore treatments are expected to show current value growth, whilst antipruritics is set to decline. Haemorrhoid treatments is expected to see value growth, mainly due to price rises, but also due to some consumers suffering from symptoms due to lifestyles triggered by COVID-...
Euromonitor International's Dermatologicals in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Dermatologicals is set to see similar slow current value growth in 2022 as witnessed in 2021, but performances are expected to vary depending on the category. For example, haemorrhoid treatments, hair loss treatments and cold sore treatments are expected to show current value growth, whilst antipruritics is set to decline. Haemorrhoid treatments is expected to see value growth, mainly due to price rises, but also due to some consumers suffering from symptoms due to lifestyles triggered by COVID-...
Euromonitor International's Dermatologicals in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
26 Pages
- Dermatologicals in Japan
- Euromonitor International
- October 2022
- List Of Contents And Tables
- DERMATOLOGICALS IN JAPAN
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Growth of dermatologicals remains stable in 2022, but performances vary across categories
- Reduced activity and prolonged telecommuting maintain sales of haemorrhoid treatments
- COVID-19 increases the time spent at home, and the demand for self-care for scalp problems and thinning hair increases
- PROSPECTS AND OPPORTUNITIES
- Dermatologicals will remain steady after 2023
- New lifestyles and impact of COVID-19 to maintain sales of haemorrhoid treatments in the early forecast period
- Hair loss treatments expected to grow, but fierce competition will require brands to consider pricing and distribution strategies
- CATEGORY DATA
- Table 1 Sales of Dermatologicals by Category: Value 2017-2022
- Table 2 Sales of Dermatologicals by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Dermatologicals: % Value 2018-2022
- Table 4 LBN Brand Shares of Dermatologicals: % Value 2019-2022
- Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
- Table 6 Forecast Sales of Dermatologicals by Category: Value 2022-2027
- Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN JAPAN
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 9 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 10 Sales of Consumer Health by Category: Value 2017-2022
- Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 16 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2021-2022
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 2 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.